These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20877134)

  • 1. Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro.
    Quintieri L; Bortolozzo S; Stragliotto S; Moro S; Pavanetto M; Nassi A; Palatini P; Floreani M
    Drug Metab Pharmacokinet; 2010; 25(5):466-76. PubMed ID: 20877134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cytochrome P450 2C8-mediated drug metabolism by the flavonoid diosmetin.
    Quintieri L; Palatini P; Moro S; Floreani M
    Drug Metab Pharmacokinet; 2011; 26(6):559-68. PubMed ID: 21791871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of curcumin on activity of cytochrome P450 2C9 enzyme in human and 2C11 in rat liver microsomes.
    Wang Z; Sun W; Huang CK; Wang L; Xia MM; Cui X; Hu GX; Wang ZS
    Drug Dev Ind Pharm; 2015 Apr; 41(4):613-6. PubMed ID: 24517573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison in the in vitro inhibitory effects of major phytocannabinoids and polycyclic aromatic hydrocarbons contained in marijuana smoke on cytochrome P450 2C9 activity.
    Yamaori S; Koeda K; Kushihara M; Hada Y; Yamamoto I; Watanabe K
    Drug Metab Pharmacokinet; 2012; 27(3):294-300. PubMed ID: 22166891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
    Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD
    J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cytochromes P450 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitro.
    Ufer M; Svensson JO; Krausz KW; Gelboin HV; Rane A; Tybring G
    Eur J Clin Pharmacol; 2004 May; 60(3):173-82. PubMed ID: 15054565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes.
    Nakashima A; Kawashita H; Masuda N; Saxer C; Niina M; Nagae Y; Iwasaki K
    Xenobiotica; 2005 Jun; 35(6):589-602. PubMed ID: 16192110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ethanol on S-warfarin and diclofenac metabolism by recombinant human CYP2C9.1.
    Tatsumi A; Ikegami Y; Morii R; Sugiyama M; Kadobayashi M; Iwakawa S
    Biol Pharm Bull; 2009 Mar; 32(3):517-9. PubMed ID: 19252308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro.
    Chang SY; Li W; Traeger SC; Wang B; Cui D; Zhang H; Wen B; Rodrigues AD
    Drug Metab Dispos; 2008 Dec; 36(12):2513-22. PubMed ID: 18787056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid.
    Melet A; Assrir N; Jean P; Pilar Lopez-Garcia M; Marques-Soares C; Jaouen M; Dansette PM; Sari MA; Mansuy D
    Arch Biochem Biophys; 2003 Jan; 409(1):80-91. PubMed ID: 12464247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1.
    Doostdar H; Burke MD; Mayer RT
    Toxicology; 2000 Apr; 144(1-3):31-8. PubMed ID: 10781868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenaline.
    Gervasini G; Martínez C; Agúndez JA; García-Gamito FJ; Benítez J
    Pharmacogenetics; 2001 Feb; 11(1):29-37. PubMed ID: 11207028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways.
    Bort R; Macé K; Boobis A; Gómez-Lechón MJ; Pfeifer A; Castell J
    Biochem Pharmacol; 1999 Sep; 58(5):787-96. PubMed ID: 10449188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6.
    Voorman RL; Payne NA; Wienkers LC; Hauer MJ; Sanders PE
    Drug Metab Dispos; 2001 Jan; 29(1):41-7. PubMed ID: 11124228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
    Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
    Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diclofenac and its derivatives as tools for studying human cytochromes P450 active sites: particular efficiency and regioselectivity of P450 2Cs.
    Mancy A; Antignac M; Minoletti C; Dijols S; Mouries V; Duong NT; Battioni P; Dansette PM; Mansuy D
    Biochemistry; 1999 Oct; 38(43):14264-70. PubMed ID: 10572000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of CYP2C9 inhibition by flavones and flavonols.
    Si D; Wang Y; Zhou YH; Guo Y; Wang J; Zhou H; Li ZS; Fawcett JP
    Drug Metab Dispos; 2009 Mar; 37(3):629-34. PubMed ID: 19074529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of human liver cytochrome P450 2C9 in the metabolism of a novel alpha4beta1/alpha4beta7 dual antagonist, TR-14035.
    Tsuda-Tsukimoto M; Ogasawara Y; Kume T
    Drug Metab Pharmacokinet; 2005 Apr; 20(2):127-34. PubMed ID: 15855725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of cytochrome P450 2C9-mediated metabolism: mechanistic evidence in support of kinetic observations.
    Hutzler JM; Wienkers LC; Wahlstrom JL; Carlson TJ; Tracy TS
    Arch Biochem Biophys; 2003 Feb; 410(1):16-24. PubMed ID: 12559973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I.
    Mo SL; Zhou ZW; Yang LP; Wei MQ; Zhou SF
    Curr Drug Metab; 2009 Dec; 10(10):1075-126. PubMed ID: 20167001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.